LDRTC Trademark

Trademark Overview


On Monday, February 19, 2024, a trademark application was filed for LDRTC with the United States Patent and Trademark Office. The USPTO has given the LDRTC trademark a serial number of 98411447. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 3, 2025. This trademark is owned by Lysosomal & Rare Disorders Research & Treatment Center, Inc. The LDRTC trademark is filed in the Education & Entertainment Services category with the following description:

Clinical Research and Treatment
ldrtc

General Information


Serial Number98411447
Word MarkLDRTC
Filing DateMonday, February 19, 2024
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, January 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesClinical Research and Treatment
Description of MarkThe mark consists of teal color.
Pseudo MarkLYSOSOMAL AND RARE DISORDERS RESEARCH AND TREATMENT CENTER
Indication of Colors claimedThe color(s) Teal is/are claimed as a feature of the mark.

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateSaturday, June 29, 2024
Primary Code041
First Use Anywhere DateMonday, January 1, 2024
First Use In Commerce DateMonday, January 1, 2024

Trademark Owner History


Party NameLysosomal & Rare Disorders Research & Treatment Center, Inc
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFairfax, VA 22030

Trademark Events


Event DateEvent Description
Monday, February 19, 2024NEW APPLICATION ENTERED
Sunday, June 30, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 10, 2024ASSIGNED TO EXAMINER
Tuesday, September 17, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 17, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 3, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 3, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Related Keywords


ldrtc treatment research clinical